C.R. Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
pos +0.00
Today's Range: 230.57 - 234.43 | BCR Avg Daily Volume: 537,700
Last Update: 01/20/17 - 4:02 PM EST
Volume: 0
YTD Performance: 3.03%
Open: $0.00
Previous Close: $231.88
52 Week Range: $176.95 - $239.43
Oustanding Shares: 73,526,324
Market Cap: 17,049,284,009
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 2 2 2
Moderate Buy 1 1 1 1
Hold 10 11 11 11
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.37 2.64 2.64 2.64
Latest Dividend: 0.26
Latest Dividend Yield: 0.45%
Dividend Ex-Date: 01/19/17
Price Earnings Ratio: 34.61
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
34.61 34.60 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.12% 30.83% 71.19%
Revenue 2.80 0.10 0.05
Net Income -54.00 -0.70 -0.36
EPS -52.90 -0.70 -0.34
Earnings for BCR:
Revenue 3.42B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $2.73 $2.61 $10.26 $11.41
Number of Analysts 13 6 13 13
High Estimate $2.75 $2.73 $10.27 $11.71
Low Estimate $2.71 $2.55 $10.23 $11.26
Prior Year $2.43 $2.34 $9.08 $10.26
Growth Rate (Year over Year) 12.50% 11.54% 12.97% 11.27%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Dec 12, 2016 | 7:50 AM EST
BCR was upgraded to Outperform, BMO Capital said. Valuation call, based on a $245 price target.
Oct 26, 2016 | 7:07 AM EDT
BCR was upgraded from Market Perform to Outperform, BMO Capital said. Valuation call, based on a $240 price target.
These sectors are full of high-priced, low-growth stocks.
The leadership is quite stark.
Let me give you the unassailable themes.
There is so much buying power in so many new areas.
Traders should look to go long BCR near $210 if it pulls back.
Buyers should stay on the sidelines of Bard until a base is formed, potentially at a lower level.
Two significant, but subtle forces may threaten the group in the next 12 months.
We would begin trimming our position with a stop-loss just below $180.

Columnist Conversations

we are picking this up with the bullish flow, strong volume and decent chart BOUGHT MDLZ APR 4...
IBM (IBM)  reported numbers last night that, as expected, came in ahead of Wall Street consensus but were...
That 9.09% NYC MTA increase.... not reflected in your COLA (cost of living adjustment) for Social Security, or...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.